InvestSMART

Healius Limited (ASX: HLS) - ETF Exposure

Current share price for HLS : $0.420 0.005 (1.20%)+

Healius Limited (HLS) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is an Australian healthcare company that provides medical and related services such as private medical laboratory and pathology services across the country.

HLS General Information +

ASX Code HLS
Website http://www.healius.com.au
Industry/Sector Health Care Services
Market Cap ($M) 304
HLS Share Price $0.420
Day High $0.423
Day Low $0.405
Last Close $0.415
HLS Share Price Movement $0.01 ( 1.20% )
Prices as at 16:40, 7 Aug 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to HLS

Healius Limited (HLS) is held across 13 ETFs spanning strategies that include health care services exposure . Its weighting in those funds means performance can have an outsized influence - when HLS moves, funds like ISO, SSO, QOZ, MQAE and DACE that hold it can move with it.

For more concentrated exposure, ETFs such as ISO (iShares S&P/ASX Small Ordinaries ETF Index Fund) allocate about 0.1% to HLS , while the average exposure across all 13 ETFs that hold it is around 0% .

Top ETF holdings

Last updated: ETF data and holdings as at 9 August 2026

Own HLS directly or through an ETF?

How does holding Healius Limited (HLS) shares directly compare to ETFs that include it?

HLS Direct
ISO
ASX 		SSO
ASX 		QOZ
ASX 		MQAE
ASX 		DACE
ASX
Holdings 1 company 198 holdings 201 holdings 201 holdings 215 holdings 470 holdings
HLS Weight 100% 0.1% 0.1% 0% 0% 0%
Diversification Single Stock Broad Broad Broad Broad Broad
Annual Cost Brokerage only 0.55% p.a. 0.5% p.a. 0.4% p.a. 0.03% p.a. 0.28% p.a.
Approx. Yield - 4.19% 8.94% 3.72% 2.47% 2.93%
Star Ratings - starstarstar starstar starstarstarstar starstarstar starstarstarstar

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not HLS's direct yield. Annual cost uses each ETF's MER.

HLS Exposure on $10,000 investment

How a $10,000 investment in Healius Limited (HLS) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Healius Limited (HLS) Direct share $0.420 12% +$1,200 $11,200
iShares S&P/ASX Small Ordinaries ETF Index Fund (ISO) Equity - Australia Small/Mid Cap $5.210 6.11% +$611 $10,611
SPDR S&P/ASX Small Ordinaries Fund (SSO) Equity - Australia Small/Mid Cap $15.000 6.31% +$631 $10,631
Betashares FTSE RAFI Australia 200 ETF (QOZ) Equity - Australia $19.850 2.21% +$221 $10,221
Macquarie Core Australian Equity Active ETF (MQAE) Equity - Australia Strategy $12.500 3.31% +$331 $10,331
Dimensional Australian Core Equity (Managed Fund) (DACE) Equity - Australia Strategy $19.500 3.89% +$389 $10,389

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Healius Limited (HLS) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Result 41.3¢ 100% 9 May 2025 23 May 2025 - - -
HFResult 6¢ 100% 7 Sep 2022 21 Sep 2022 - - -
Result 10¢ 100% 24 Mar 2022 5 Apr 2022 - - -

See all dividends from Healius Limited (HLS) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Healius Limited (HLS) price-sensitive announcements

HLS - Healius transitions pathology arrangements with Ramsay
Healius Limited has announced a new national agreement framework with the wholly-owned sub
Healius Limited (HLS)
26 Jun 2026 | 5:09 PM
HLS - FY26 trading update and strategic review of assets
Healius Limited announced a trading update for FY26, projecting an underlying EBITDA betwe
Healius Limited (HLS)
13 May 2026 | 8:17 AM
HLS - Healius announces 1H 2026 results
Healius Limited announced its financial results for the first half of the fiscal year 2026
Healius Limited (HLS)
18 Feb 2026 | 8:16 AM
HLS - Half Year 2026 Results Presentation
Healius Limited's Half Year 2026 Results Presentation highlighted a group revenue growth o
Healius Limited (HLS)
18 Feb 2026 | 8:16 AM

Healius Limited (HLS) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Healius Limited (HLS)
ORDINARY FULLY PAID
 Health Care $305 Change of Share Registry Provider 6 Aug 2026 4:21PM $0.415 $0.420 risen by 1.20%
Healius Limited (HLS)
ORDINARY FULLY PAID
 Health Care $305 Webcast details for Healius FY26 Results 30 Jul 2026 5:02PM $0.365 $0.420 risen by 15.07%
Healius Limited (HLS)
ORDINARY FULLY PAID
 Health Care $305 Ceasing to be a substantial holder 10 Jul 2026 8:22AM $0.390 $0.420 risen by 7.69%
Healius Limited (HLS)
ORDINARY FULLY PAID
 Health Care $305 Becoming a substantial holder 7 Jul 2026 8:23AM $0.385 $0.420 risen by 9.09%
Healius Limited (HLS)
ORDINARY FULLY PAID
 Health Care $305 Ceasing to be a substantial holder 7 Jul 2026 8:18AM $0.385 $0.420 risen by 9.09%
Healius Limited (HLS)
ORDINARY FULLY PAID
 Health Care $305 Change of Director's Interest Notice - Paul Anderson 3 Jul 2026 6:35PM $0.375 $0.420 risen by 12%

HLS Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2027F C2 -$2.00 0.00% 0.00 0.00 0.00% 0.0%
2026F C2 -$2.00 -59.40% 0.00 0.00 0.00% 0.0%
2025A -$35.80 -$4.90 -470.70% 0.00 0.00 0.00% 100.0%

HLS Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2025 A 2026 F 2027 F 2025 A 2026 F 2027 F 2025 A 2026 F 2027 F
Australian Clinical Labs Limited (ACL) $450M -0.0336 0.0000 0.0000 13.3076 0.0000 0.0000 5.19% 0.00% 0.00%
Healius Limited (HLS) $301M -4.7068 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Integral Diagnostics Limited (IDX) $832M -1.3095 0.5666 0.1667 29.1123 18.5833 15.9286 2.91% 3.59% 3.14%
Sonic Healthcare Limited (SHL) $10,992M 0.0625 0.1127 0.1161 20.8435 18.7316 16.7836 4.81% 4.92% 5.01%

HLS Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 3.00 0.00 0.52 0.00
Market 0.61 18.00 1.68 1.05
Sector 0.72 18.80 1.66 1.85

HLS Directors

Name Position Start Date
Mr Paul Anderson Chief Executive Officer, Managing Director 5 Mar 2024
Ms Kathryn (Kate) Mary McKenzie Non-Executive Chairman, Non-Executive Director 25 Feb 2021
Mr Christopher John Hall Non-Executive Director 30 Sep 2025
Professor Bruce Gregory Robinson AC Non-Executive Director 2 Feb 2026
Ms Sally Evans Non-Executive Director 21 Aug 2018
Ms Katherine (Kathy) Ostin Non-Executive Director 1 Dec 2024
Mr Charlie Taylor Non-Executive Director 20 Mar 2023
Mr Steven Rubic Non-Executive Director 1 Dec 2025

Healius Limited (HLS) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
12 Mar 2026 RUBIC, Steven Buy Direct Shares 130,000 $0.595 $77,350.000
12 Mar 2026 OSTIN, Katherine (Kathy) Buy Indirect Shares 8,547 $0.585 $4,999.995
9 Mar 2026 OSTIN, Katherine (Kathy) Buy Indirect Shares 16,264 $0.615 $9,999.107

See all changes in directors' interest & trades for Healius Limited (HLS) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

HLS Management

Name Position
Puneet Nagi Chief Operating Officer
Kylie Brown Company Secretary
Andrew Peter Thomson Company Secretary
Rodney Rudling Group Executive, Clinical Integration
Anthea Muir Group Executive, Customer & Commercial
Prasad Arav Group Executive, Digital & Technology, and Strategy
Arjun Narang Group Executive, Operations
Paula Bayliss Group Executive, People & Culture
Kylie Brown Group General Counsel, Company Secretary and Chief Risk Officer

HLS Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Healius Limited (HLS). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
68,203,075 (11.97%) Tanarra Capital Australia Pty Ltd
64,372,525 (8.87%) Australian Retirement Trust Pty Ltd
45,433,327 (7.97%) Host-Plus Pty Limited
53,280,727 (7.34%) Spheria Asset Management Pty Ltd
46,591,050 (6.42%) Mitsubishi UFJ Financial Group, Inc
46,578,502 (6.41%) First Sentier Investors Holdings Pty Limited
44,359,387 (6.11%) Citicorp Global Markets Limited
36,366,331 (5.01%) Vanguard Group

HLS Calendar of Events

Date Event
17 February 2027 Report (Interim)
25 September 2026 Report (Annual)
20 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.